Boston Scientific Corp
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Medical Devices
業務概覽 Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
公司地址 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
電話號碼 +1 508 683-4000
傳真號碼 +1 508 650-8923
公司網頁 https://www.bostonscientific.com
員工數量 59000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer -- 18/03/2026
Mr. Vance R. Brown Executive Vice President, General Counsel and Corporate Secretary 美元 659.09K 18/03/2026
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer 美元 591.85K 18/03/2026
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiovascular 美元 892.60K 18/03/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 美元 1.44M 18/03/2026
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific 美元 744.82K 18/03/2026
Mr. Padraig A. O’Connor Executive Vice President, Global Operations -- 18/03/2026
Ms. Emily M. Woodworth Senior Vice President, Global Controller and Chief Accounting Officer -- 18/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Edward J. Ludwig Lead Independent Director 18/03/2026
Mr. David S. Wichmann Independent Director 18/03/2026
Ms. Ellen M. Zane Independent Director 18/03/2026
Mr. Yoshiaki Fujimori Independent Director 05/02/2026
Senator John E. Sununu Independent Director 18/03/2026
Ms. Catherine R. Smith Independent Director 18/03/2026
Ms. Susan E. Morano Independent Director 18/03/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 18/03/2026
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director 18/03/2026
Mr. David C. Habiger Independent Director 18/03/2026
Mr. Christophe Pierre Weber Director 23/02/2026
Ms. Catherine R. Smith Director 23/02/2026
Dr. Cheryl B. Pegus, M.D. Independent Director 18/03/2026
 
所屬ETF (更新日期: 02/05/2026 02:34)
代號 名稱 佔比% ▼ 持有日期
AIEQAmplify AI Powered Equity ETF<0.000001%01/04/2026
AIOVirtus AI & Tech Opp Fund<0.000001%30/11/2025
AMOMQRAFT AI-Enhanced US Large Cap Mmntm ETF<0.000001%03/10/2025
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
AQECAQE Core ETF<0.000001%28/11/2025
AVUQAvantis U.S. Quality ETF<0.000001%01/04/2026
BCGSBancreek Global Select ETF<0.000001%21/04/2026
BCUSBANCREEK U.S. Large Cap ETF<0.000001%15/04/2026
BFORBarron's 400 ETF<0.000001%20/03/2026
BFREWestwood LBRTY Global Equity ETF<0.000001%24/02/2026
BKWOBNY Mellon Women's Opportunities ETF<0.000001%16/09/2025
BLCRiShares Large Cap Core Active ETF<0.000001%08/12/2025
BRNYBurney U.S. Factor Rotation ETF<0.000001%02/02/2026
CAMLCongress Large Cap Growth ETF<0.000001%08/04/2026
CGGRCapital Group Growth ETF<0.000001%28/02/2026
CIIBlackRock Enhanced Large Cap Core Fund<0.000001%31/12/2025
CVSECalvert US Select Equity ETF<0.000001%15/10/2025
DFVXDimensional US Large Cap Vector ETF<0.000001%20/04/2026
DIVAAGFiQ Hedged Dividend Income<0.000001%16/06/2022
DVOLFirstTrustDorseyWrightMomt&LwVolatil ETF<0.000001%19/10/2025
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17   18    19    20    21    22    23  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.